Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 237 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2778 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SITAGLIPTIN/METFORMIN XR 500MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185970
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185973
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185976
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185982
APO-SITAGLIPTIN/METFORMIN XR 1000MG 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185985
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-09 2023-04-06 186575
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-16 2023-04-06 187238
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-06 2023-04-21 188973
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-14 2024-02-02 189647
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-27 2023-06-29 190874
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-06 2023-06-09 191880
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-06 2023-05-12 191898
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-19 2023-07-21 192800
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-19 2023-06-23 192818
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-26 2023-07-21 193218
APO-OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-02 2023-08-12 193614
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-09 2023-09-22 194571
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-08-04 195091
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-23 196297
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-04 196300

Showing 2921 to 2940 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-CARBAMAZEPINE Discontinued 2020-02-19 2020-02-19 106679
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-NORTRIPTYLINE 10MG CAPSULE Discontinued 2017-03-13 2017-03-13 1145
APO-NORTRIPTYLINE 25MG CAPSULE Discontinued 2017-03-13 2017-03-13 1155
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
DOCUSATE SODIUM CAPSULES 100MG CAPSULE Discontinued 2018-02-23 2018-09-15 40738
APO-AMOXI 250MG CAPSULE Discontinued 2018-09-07 2019-02-13 60171
APO-AMOXI 500MG CAPSULE Discontinued 2018-09-07 2018-11-09 60174
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-CELECOXIB 100MG CAPSULE To be discontinued 2018-09-07 2018-12-11 60363
APO-CELECOXIB 200MG CAPSULE Discontinued 2018-09-07 2021-01-21 60366
APO-CLINDAMYCIN 150MG CAPSULE To be discontinued 2018-09-07 2018-12-28 60396
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399

Showing 41 to 60 of 356